Overview

Study to Evaluate Daptomycin Given During Dialysis and After Dialysis

Status:
Completed
Trial end date:
2009-07-17
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether daptomycin at a higher dose given during the last 30 minutes of a dialysis session is equal to a lower dose of daptomycin given after a dialysis session.
Phase:
Phase 1
Details
Lead Sponsor:
Cubist Pharmaceuticals LLC
Treatments:
Daptomycin